Neogen Overview
- Founded
-
1982

- Status
-
Public
- Employees
-
2,108

- Stock Symbol
-
NEOG

- Investments
-
49
- Share Price
-
$19.96
- (As of Monday Closing)
Neogen General Information
Description
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for global food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Contact Information
- 620 Lesher Place
- Lansing, MI 48912
- United States
Neogen Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$19.96 | $20.04 | $10.49 - $36.90 | $4.3B | 216M | 3.31M | -$0.04 |
Neogen Financials Summary
In Thousands, USD |
TTM 30-Nov-2022 | FY 2022 31-May-2022 | FY 2021 31-May-2021 | FY 2020 31-May-2020 |
---|---|---|---|---|
EV | 3,231,032 | 2,473,862 | 4,603,700 | 3,440,386 |
Revenue | 630,719 | 527,159 | 468,459 | 418,170 |
EBITDA | 42,456 | 82,634 | 94,695 | 84,709 |
Net Income | (16,230) | 48,307 | 60,882 | 59,475 |
Total Assets | 4,563,242 | 992,929 | 920,192 | 797,182 |
Total Debt | 923,962 | 0 | 0 | 0 |
Neogen Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Neogen Comparisons
Industry
Financing
Details
Neogen Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
MSA Safety | Corporation | Cranberry Township, PA | 0000 | 000000 - 000 | ||
0000 00000 0000000 | Private Equity-Backed | Libourne, France | 0000 | 00000 | 00 000000 | 00000 |
Neogen Patents
Neogen Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220315991-A1 | Detecting salmonella from an environmental sample | Pending | 31-Mar-2021 | 000000000 | |
US-20220062563-A1 | Hypodermic interface assembly | Pending | 01-Sep-2020 | 0000000000 | |
US-20220031961-A1 | Hypodermic interface assembly | Pending | 28-Jul-2020 | 0000000000 | 0 |
US-20220031962-A1 | Hypodermic interface assembly | Pending | 28-Jul-2020 | 000000000 | |
US-D839380-S1 | Bait station | Active | 17-Aug-2017 |
Neogen Executive Team (29)
Neogen Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
Catherine Woteki | Neogen | Board Member | 000 0000 |
Darci Vetter | Neogen | Board Member | 000 0000 |
James Borel | Self | Chairman & Board Member | 000 0000 |
James Tobin | Neogen | Board Member | 000 0000 |
Jeffrey Capello | Neogen | Board Member | 000 0000 |
Neogen Signals
Neogen Investments & Acquisitions (49)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00 (00'0 0000 | 01-Sep-2022 | 0000000000 | 00.00 | Other Commercial Products | 0000 0000 |
0000-000 0000 | 01-Jul-2022 | 0000000000 | 00.000 | Distributors/Wholesale | 00000 000 |
000 00000 000 | 09-Dec-2021 | 0000000000 | 000.00 | Laboratory Services (Healthcare) | 00000000 |
000000 000000 | 30-Nov-2021 | 0000000000 | Laboratory Services (Healthcare) | ||
Delf (UK) | 30-Nov-2021 | Merger/Acquisition | Industrial Chemicals | 00000 000 |
Neogen Subsidiaries (13)
Company Name | Industry | Location | Founded |
---|---|---|---|
CAPInnoVet | Pharmaceuticals | Atlanta, GA | 2014 |
000 00000 00000000 | Laboratory Services (Healthcare) | Spokane, WA | 0000 |
00000 000000000000 | Biotechnology | Aracatuba, Brazil | 0000 |
000000 0000000000 | Laboratory Services (Healthcare) | London, United Kingdom | 0000 |
0000000000 | Distributors/Wholesale | Milan, Italy | 0000 |
Neogen ESG
Risk Overview
Risk Rating
Updated June, 03, 2022
19.18 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
Percentile

Healthcare
Industry
00 of 635
Rank
Percentile

Medical Supplies
Subindustry
00 of 59
Rank
Percentile
